Article Sidebar

PDF (Tiếng Việt)
Published: 2026-06-25
Abstract Views: 10
Views PDF (Tiếng Việt): 5
DOI: https://doi.org/10.52163/yhc.v67i6.5506
Issue
Vol. 67 No. 6
Section
Articles
How to Cite
Dung, H. T., Âu, H. Đình, & Lan, N. P. (2026). SURVEY OF NON-ALCOHOLIC FATTY LIVER DISEASE USING ULTRASOUND-GUIDED ATTENUATION PARAMETER (UGAP) IN ELDERLY PATIENTS WITH METABOLIC DISORDERS. Vietnam Journal of Community Medicine, 67(6). https://doi.org/10.52163/yhc.v67i6.5506

SURVEY OF NON-ALCOHOLIC FATTY LIVER DISEASE USING ULTRASOUND-GUIDED ATTENUATION PARAMETER (UGAP) IN ELDERLY PATIENTS WITH METABOLIC DISORDERS.

Ha Thuy Dung1, Hoang Dinh Au1,2,3, Nguyen Phuong Lan1
1 National Geriatric Hospital
2 Hanoi Medical University Hospital
3 Hanoi Medical University

Main Article Content

Abstract

Objective: To evaluate non-alcoholic fatty liver disease (NAFLD) in elderly patients with metabolic disorders using quantitative ultrasound assessment of hepatic steatosis (UGAP).


Materials and Methods: A cross-sectional descriptive study was conducted on 168 patients aged ≥60 years with at least one metabolic disorder (diabetes mellitus, dyslipidemia, hypertension, or abdominal obesity [waist circumference ≥90 cm in men and ≥80 cm in women]) who attended National Geriatric Hospital from November 15, 2025 to December 30, 2025. Hepatic steatosis was assessed using the ultrasound-guided attenuation parameter (UGAP) technique on the LOGIQ Fortis (GE Healthcare). Results: The prevalence of NAFLD among the 168 elderly patients with metabolic disorders was 44.6%. Regression analysis showed that age and abdominal obesity were two factors associated with NAFLD. Abdominal obesity was associated with the severity of hepatic steatosis. Conclusion: Abdominal obesity is a predictor of NAFLD in elderly individuals. In contrast, diabetes mellitus, dyslipidemia, and hypertension were not associated with an increased risk of NAFLD in this population

Article Details

Keywords

Fatty liver; NAFLD; quantitative ultrasound assessment of hepatic steatosis; UGAP; metabolic disorders; elderly.

References

1. Carr RM, Oranu A, Khungar V. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. Gastroenterol Clin North Am. 2016;45(4):639–652. doi:10.1016/j.gtc.2016.07.003
2. Alqahtani SA, Schattenberg JM. NAFLD in the Elderly. Clin Interv Aging. 2021;16:1633–1649. doi:10.2147/CIA.S296315
3. Le MH, et al. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022;20(12):2809–2817.e28. doi:10.1016/j.cgh.2021.12.002.
4. Nguyễn Văn, T., P. Lê Hữu, and B. Phạm Hòa, KHẢO SÁT TỶ LỆ BỆNH GAN NHIỄM MỠ KHÔNG DO RƯỢU VÀ MỘT SỐ YẾU TỐ LIÊN QUAN Ở BỆNH NHÂN CAO TUỔI ĐÁI THÁO ĐƯỜNG TÍP 2. Tạp chí Y học Việt Nam, 2025. 552(1).
5. Ogino Y, et al. The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease. JGH Open. 2021;5(8):947–952. doi:10.1002/jgh3.12569.
6. Ono H, Akahoshi K, Kai M. Change in waist circumference and lifestyle habit factors as a predictor of metabolic risk among middle-aged and elderly Japanese people: population-based retrospective 10-year follow-up study from 2008 to 2017. Arch Public Health. 2022;80(1):75. doi:10.1186/s13690-022-00829-9.
7. World Health Organization, Waist circumference and waist-hip ratio: report of a WHO expert consultation. Report of a WHO Expert Consultation. 2008. p. 39. https://apps.who.int/iris/handle/10665/44583
8. Song QR, et al. Severity of Nonalcoholic Fatty Liver Disease is Associated With Cardiovascular Outcomes in Patients With Prehypertension or Hypertension: A Community-Based Cohort Study. Front Endocrinol (Lausanne). 2022;13:942647. doi:10.3389/fendo.2022.942647